CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Baytacare Pharmaceutical Co., Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Baytacare Pharmaceutical Co., Ltd
No. 3 2nd Road, Gaoxin District
Phone: +86 43264641900p:+86 43264641900 Jilin, JLN  132011  Hong Kong
This company is no longer actively traded on any major stock exchange.
Business Summary
Baytacare Pharmaceutical Co., Ltd., formerly Northeast Tiger Pharmaceutical Co., Ltd., is principally engaged in the sales of pharmaceutical products. The Company mainly operates through two business segments. The Medicines Business segment is engaged in the development, manufacture and sales of medicines. The Chinese Herbs Business segment is engaged in the planting, cultivation and sales of Chinese herbs. The Company mainly conducts its businesses in Mainland China. The Company is also engaged in the investment holding business through its subsidiaries in the People’s Republic of China (the PRC). Its principal subsidiary includes Antao County Northeast Tiger Xinxing New Products Co., Limited.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201912/31/2018Yes----

Industries
SIC Code Description
0139 Field crops, except cash grains, not elsewhere classified
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board YaoFang 35 6/15/2018 6/15/2018
Chief Financial Officer NanZhu 43 11/28/2016 11/28/2016
Executive Director BingyanCui
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 10 (As of 6/30/2019)
Outstanding Shares: 858,054,000 (As of 6/30/2019)
Stock Exchange: HKG


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023